Status:

WITHDRAWN

A Breathing-Based Meditation Intervention for Patients With Treatment Resistant Late Life Depression

Lead Sponsor:

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Conditions:

Late Life Depression

Eligibility:

All Genders

60-80 years

Phase:

PHASE1

Brief Summary

Late-life depression affects 2-8% of seniors and causes high rates of caregiver distress and risk of suicide. To exacerbate the problem, antidepressants, the cornerstone of therapy, are resistant in 5...

Detailed Description

RECRUITMENT AND CONSENT: Patients will be recruited from Victoria Hospital, London Health Sciences Centre or Parkwood Mental Health, St. Joseph's Health Care London. Patients will be screened and rec...

Eligibility Criteria

Inclusion

  • 60-80 years of age
  • major depressive disorder, as per the results of an interview by a trained rater using the Structured Clinical Interview for DSM-5 and subsequently confirmed by the psychiatrist
  • Mild to moderate depression as confirmed by a score on the HAM-D 17 between 8 and 23
  • Have failed at least two trials of antidepressants, given at adequate doses for adequate duration during the current episode
  • Able to follow verbal instructions and sit without physical discomfort for 45 minutes
  • Willing and able to attend at least 75% of all Sudarshan Kriya Yoga (SKY) sessions
  • Willing to dedicate 25-30 minutes/day to SKY practice at home
  • Low risk of suicide based on a clinical initial interview and during follow-up interviews at weeks 4, 8 and 12.

Exclusion

  • Uncontrolled hypertension, seizure disorder, psychosis, substance abuse, or dementia
  • Currently participating in other similar studies or currently practicing any type of formal meditation, mindfulness or breathing techniques
  • A major surgery within 6 weeks prior to commencement of or scheduled during, the study intervention
  • A traumatic brain injury
  • Any contraindications to MRI will also be excluded
  • Healthy control participants must have no significant mental health issues, or contraindications to MRI.

Key Trial Info

Start Date :

January 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 31 2022

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT03368560

Start Date

January 1 2020

End Date

December 31 2022

Last Update

June 25 2018

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.